These are typically patients with advanced type 2 diabetes with increased insulin resistance and impaired peripheral insulin sensitivity, respectively, which has been repeatedly associated with adverse cardiovascular outcome and a high mortality rate [4, 5]. The gene discussed is INS; the disease is Insulin resistance.